Midcap stocks which can ride the Pharmaceuticals megatrend
| Company | CMP (Rs) | P/E (x) | P/BV (x) | D/E (Curr FY, x) | EV/EBIT | RoE (Latest, %) | RoCE (Latest, %) | Dividend Yield (%) |
|---|---|---|---|---|---|---|---|---|
| GSK PHARMA | 2,439.8 | 39.9 | 18.2 | 0.0 | 37.5 | 47.2% | 64.1% | 2.2% |
| ABBOTT INDIA | 27,934.6 | 38.2 | 12.4 | 0.0 | 6.2 | 33.6% | 45.2% | 1.7% |
| AJANTA PHARMA | 3,174.7 | 37.6 | 8.8 | 0.0 | 26.9 | 24.3% | 32.0% | 0.9% |
| NARAYANA HRUDAYALAYA | 1,839.0 | 48.0 | 9.0 | 0.6 | 32.9 | 21.8% | 19.6% | 0.2% |
| LUPIN | 2,273.9 | 19.4 | 4.6 | 0.3 | 21.9 | 19.3% | 22.8% | 0.5% |
| CADILA HEALTHCARE | 1,011.3 | 20.6 | 3.9 | 0.1 | 14.4 | 19.3% | 26.0% | 1.1% |
| ANTHEM BIOSCIENCES LTD. | 783.5 | NM | 15.5 | 0.0 | -0.1 | 19.0% | 27.5% | 0.0% |
| ALKEM LABORATORIES | 5,485.3 | 27.1 | 4.7 | 0.1 | 21.8 | 18.5% | 21.6% | 0.8% |
| DR. REDDYS LAB | 1,337.0 | 26.9 | 2.9 | 0.1 | 12.3 | 17.1% | 23.3% | 0.6% |
| MANKIND PHARMA | 2,503.9 | 57.5 | 6.6 | 0.6 | 36.5 | 14.0% | 14.9% | 0.0% |
| GLENMARK PHARMA | 2,325.0 | 61.6 | 6.6 | 0.2 | 27.4 | 11.8% | 17.2% | 0.1% |
| MAX HEALTHCARE INSTITUTE | 1,050.0 | 72.0 | 9.9 | 0.3 | 69.0 | 11.6% | 13.6% | 0.1% |
| IPCA LABS | 1,605.8 | 43.0 | 5.2 | 0.2 | 32.0 | 11.3% | 16.3% | 0.2% |
| AUROBINDO PHARMA | 1,511.3 | 25.0 | 2.4 | 0.2 | 12.1 | 10.7% | 16.1% | 0.0% |
| ASTER DM HEALTHCARE | 753.8 | 84.1 | 8.5 | 0.2 | 39.5 | 9.8% | 15.5% | 15.7% |
| LAURUS LABS | 1,324.5 | 80.4 | 13.5 | 0.6 | 50.9 | 8.0% | 13.8% | 0.1% |
| BIOCON | 430.1 | 189.0 | 2.0 | 0.8 | 19.6 | 6.7% | 8.3% | 0.1% |
* We show NM where the values are negative
Disclaimer: This is for information purposes only. These are not stock recommendations and should not be treated as such. Learn more about our recommendation services here... Also note that these screeners are based only on numbers. There is no screening for management quality.